Evidence map›Paper›PMID 29938581›Full record

ArticleAutophagy2018

AT 101 induces early mitochondrial dysfunction and HMOX1 (heme oxygenase 1) to trigger mitophagic cell death in glioma cells.

Nina Meyer, Svenja Zielke, Jonas B Michaelis, Benedikt Linder, Verena Warnsmann, Stefanie Rakel, Heinz D Osiewacz, Simone Fulda, Michel Mittelbronn, Christian Münch and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Exploring the Efficacy and Target Genes ofCurrent issues in molecular biology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Mechanism and regulation of mitophagy in liver diseases: a review.Frontiers in cell and developmental biology · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 2 countries.

Nina Meyera Experimental Neurosurgery , Goethe University Hospital Frankfurt/Main , Germany.
Svenja Zielkeb Experimental Cancer Research in Pediatrics , Goethe University Hospital Frankfurt/Main , Germany.
Jonas B Michaelisc Institute of Biochemistry II , Goethe University Hospital Frankfurt/Main , Germany.
Benedikt Lindera Experimental Neurosurgery , Goethe University Hospital Frankfurt/Main , Germany.
Verena Warnsmannd Institute of Molecular Biosciences , Goethe University Frankfurt/Main , Germany.
Stefanie Rakela Experimental Neurosurgery , Goethe University Hospital Frankfurt/Main , Germany.
Heinz D Osiewaczd Institute of Molecular Biosciences , Goethe University Frankfurt/Main , Germany.ORCID 0000-0002-0360-6994
Simone Fuldab Experimental Cancer Research in Pediatrics , Goethe University Hospital Frankfurt/Main , Germany.
Michel Mittelbronnf German Cancer Consortium (DKTK) , Partner Site Frankfurt, Frankfurt/Main , Germany.
Christian Münchc Institute of Biochemistry II , Goethe University Hospital Frankfurt/Main , Germany.ORCID 0000-0003-3832-090X
Christian Behrendsc Institute of Biochemistry II , Goethe University Hospital Frankfurt/Main , Germany.ORCID 0000-0002-9184-7607
Donat Kögela Experimental Neurosurgery , Goethe University Hospital Frankfurt/Main , Germany.ORCID 0000-0003-1209-0210
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In most cases, macroautophagy/autophagy serves to alleviate cellular stress and acts in a pro-survival manner. However, the effects of autophagy are highly contextual, and autophagic cell death (ACD) is emerging as an alternative paradigm of (stress- and drug-induced) cell demise. AT 101 ([-]-gossypol), a natural compound from cotton seeds, induces ACD in glioma cells as confirmed here by CRISPR/Cas9 knockout of ATG5 that partially, but significantly rescued cell survival following AT 101 treatment. Global proteomic analysis of AT 101-treated U87MG and U343 glioma cells revealed a robust decrease in mitochondrial protein clusters, whereas HMOX1 (heme oxygenase 1) was strongly upregulated. AT 101 rapidly triggered mitochondrial membrane depolarization, engulfment of mitochondria within autophagosomes and a significant reduction of mitochondrial mass and proteins that did not depend on the presence of BAX and BAK1. Conversely, AT 101-induced reduction of mitochondrial mass could be reversed by inhibiting autophagy with wortmannin, bafilomycin A ABBREVIATIONS: ACD, autophagic cell death; ACN, acetonitrile; AT 101, (-)-gossypol; BAF, bafilomycin A

Indexed as

AutophagyAutophagy-Related Protein 5Cell Line, TumorGliomaGossypolHeme Oxygenase-1HumansMembrane Potential, MitochondrialMitochondriaMitochondrial ProteinsMitophagyNeoplasm ProteinsProteomicsATG5 protein, humanAutophagy-Related Protein 5Gossypolgossypol acetic acidHeme Oxygenase-1Mitochondrial ProteinsNeoplasm ProteinsAutophagic cell deathbrain tumorsflow cytometryheme oxygenase 1mitophagyproteomics

Identifiers

PMID29938581
PMCPMC6135628
OpenAlexW2884592278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.